CoChat

Potentiation of the Effect of Buprenorphine/Naloxone With Gabapentin or Quetiapine

Reeves, Roy R., Ladner, Mark E. · 2014 · American Journal of Psychiatry

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2014.13111526

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 1

  1. Eckhardt K, 2000, Anesth Analg, 91, 185, 10.1213/00000539-200007000-00035 · doi:10.1213/00000539-200007000-00035 · Paper page

Cited by

See all 47

Metadata

Authors
Reeves, R. R., & Ladner, M. E.
Affiliations
From the Department of Psychiatry, Jackson VA Medical Center, Jackson, Miss.
Venue
American Journal of Psychiatry
Published
2014-06
Volume
171
Issue
6
Pages
691-691
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2131770373
Cited by
43
References
3
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 4 · 2015: 2 · 2014: 1
FWCI
4.95
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
buprenorphine/naloxone, gabapentin, quetiapine, drug potentiation, opioid antagonists, opioid withdrawal
MeSH terms
Quetiapine Fumarate, Gabapentin, Adult, Amines, Analgesics, Buprenorphine, Cyclohexanecarboxylic Acids, Dibenzothiazepines, Drug Synergism, gamma-Aminobutyric Acid, Humans, Male, Naloxone, Narcotic Antagonists, Opiate Substitution Treatment, Prescription Drug Misuse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potentiation of the Effect of Buprenorphine/Naloxone With Gabapentin or Quetiapine. https://app.cochat.ai/papers/10.1176/appi.ajp.2014.13111526
The paper
Reeves, R. R., & Ladner, M. E. (2014). Potentiation of the Effect of Buprenorphine/Naloxone With Gabapentin or Quetiapine. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13111526

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.